阿胶补血方联合生血宝合剂治疗产后贫血临床观察

Effect of Ejiao Buxue Formulas Combined with Shengxuebao Mixture in Treating Postpartum Anemia

目的观察阿胶补血方联合生血宝合剂治疗产后贫血的临床效果及安全性。方法分层随机将2018年1月—2021年1月鄱阳县人民医院收治的60例产后贫血患者分为参照组和观察组,参照组(30例)给予琥珀酸亚铁治疗,观察组(30例)给予阿胶补血方联合生血宝合剂治疗,对比2组的血细胞指标、铁代谢指标、临床疗效及不良反应发生率。结果治疗后,比较2组红细胞比容(HCT)、血红蛋白(Hb)水平及治疗总有效率,差异无统计学意义(P>0.05);2组HCT、Hb、血清铁(SI)、血清铁蛋白(SF)水平均较治疗前增高,且观察组SI、SF水平及不良反应总发生率低于参照组,差异均有统计学意义(P<0.05)。结论产后贫血患者采用阿胶补血方联合生血宝合剂治疗,可有效改善血细胞指标,且对铁代谢影响小,安全可靠,值得临床推广应用。

Objective To analyze the efficacy and safety of Ejiao Buxue formulas combined with Shengxuebao mixture in the treatment of postpartum anemia.Methods 60 postpartum anemia patients admitted to Poyang county people’s hospital from January 2018 to January 2021 were divided into a reference group and a observation group by stratified randomization,with 30 cases in each group.The reference group was treated with ferrous succinate,while the observation group was treated with Ejiao Buxue formulas combined with Shengxuebao mixture.The blood cell indicators,iron metabolism indicators,curative effect and incidence of adverse reactions be-tween the two groups were compared.Results After treatment,there was no significant difference in hematocrit(HCT),hemoglobin(Hb)level and the total effective rate between the two groups(P>0.05).The levels of HCT,Hb,serum iron(SI)and serum ferritin(SF)in the two groups were higher than those before treatment.Also,the levels of SI and SF and the incidence of adverse reactions in the observation group were lower than those in the reference group,and all the differences were statistically significant(P<0.05).Conclu-sion Treating postpartum anemia patients with Ejiao Buxue formulas combined with Shengxuebao mixture can effectively improve the blood cell indicators,and has less effect on iron metabolism.It is safe and reliable and is worthy of promotion.